LNTH
Closed
Lantheus Holdings Inc
79.42
-2.44 (-2.98%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 81.86
Day's Range: 79.03 - 81.875
Send
sign up or login to leave a comment!
When Written:
83.1
Lantheus Holdings Inc. is a company that specializes in the development, manufacture, and commercialization of diagnostic medical imaging agents and products. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts, USA.
Lantheus Holdings Inc. offers a range of diagnostic imaging agents and products, including contrast agents used in medical imaging procedures such as ultrasound, MRI, and nuclear medicine. The company's products are used in the diagnosis and treatment of various medical conditions, including cardiovascular disease, cancer, and neurological disorders.
Lantheus Holdings Inc. operates in several regions worldwide, including North America, Europe, and Asia. The company has a global network of distributors and partners, enabling it to reach a broad customer base.
In recent years, Lantheus Holdings Inc. has focused on expanding its product portfolio through strategic acquisitions and partnerships. The company has also invested in research and development to develop new imaging agents and products to meet the evolving needs of the healthcare industry.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Lantheus Holdings Inc. offers a range of diagnostic imaging agents and products, including contrast agents used in medical imaging procedures such as ultrasound, MRI, and nuclear medicine. The company's products are used in the diagnosis and treatment of various medical conditions, including cardiovascular disease, cancer, and neurological disorders.
Lantheus Holdings Inc. operates in several regions worldwide, including North America, Europe, and Asia. The company has a global network of distributors and partners, enabling it to reach a broad customer base.
In recent years, Lantheus Holdings Inc. has focused on expanding its product portfolio through strategic acquisitions and partnerships. The company has also invested in research and development to develop new imaging agents and products to meet the evolving needs of the healthcare industry.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








